Jim Watson

DNP Doctor of Nursing Practice,  Massachusetts General Hospital 

Location: India

Consulting Services

Admin and Customer Support Career Advice and Mentoring

Areas Of Interest

Serum Bactericidal Tests Apo-Quinidine Carrier Proteins Mixed Cerebral Palsy Implantable Perfusion Pump Hemorrhagic Fever, Omsk Basophil Adenoma RSS as Topics Peri implant Endosseous Healing Cystadenocarcinomas Acro-Osteolysis Syndrome Infections, Trypanosoma cruzi Acupuncture Point Prozac Tenodesis Ligularia Adenoid Cystic Carcinoma Acute Renal Colics Lateralis Posteriors, Nucleus Calcium Calmodulin Dependent Protein Kinase Type 1 Immediate Hypersensitivity Bacterial Count Radiation Therapies Reticulosis, Familial Hemophagocytic Esophageal Stenoses Resistance, Electrical Legal Obligation Trihexane Disease Cost Agnosias, Body-Image Rickamicin Pomeroy Sterilization Unicondylar Knee Arthroplasty Adenoma, alpha Cell Arrhenoblastoma Partner Notification Membrane, Basilar Carbimide, Calcium

Professional Narrative

Dr. Jim Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Mayo Clinic 2008
Senior Director, Harvard Med 2001

Education

Director Medicine, Yale School of Medicine 2012
Bachelor of science in nursing, Harvard Medical School 2002

Referees


Publications

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :